Combination of ifosfamide methotrexate, and etoposide (IMVP) as a salvage therapy for relapsed and refractory aggressive Non-Hodgkin lymphoma

Permalink: http://skupnikatalog.nsk.hr/Record/nsk.NSK01000486654/Similar
Matična publikacija: Croatian medical journal
43 (2002), 5 ; str. 550-554
Glavni autor: Aurer, Igor (-)
Ostali autori: Duraković, Nadira (-), Radman, Ivo, liječnik, Nemet, Damir, Zupančić-Šalek, Silva, Kovačević-Metelko, Jasminka, Bogdanić, Vinko, Sertić, Dubravka, Mrsić, Mirando, Mikulić, Mirta, Labar, Boris
Vrsta građe: Članak
Jezik: eng
Predmet:

APA stil citiranja

Aurer, I., Duraković, N., Radman, I., Nemet, D., Zupančić-Šalek, S., Kovačević-Metelko, J., . . . Labar, B. (2002). Combination of ifosfamide methotrexate, and etoposide (IMVP) as a salvage therapy for relapsed and refractory aggressive Non-Hodgkin lymphoma: Combination of ifosfamide methotrexate, and etoposide (IMVP) as a salvage therapy for relapsed and refractory aggressive Non-Hodgkin lymphoma : retrospective study. Croatian medical journal, p. 3.

Chicago stil citiranja

Aurer, Igor, et al. "Combination of ifosfamide methotrexate, and etoposide (IMVP) as a salvage therapy for relapsed and refractory aggressive Non-Hodgkin lymphoma: Combination of ifosfamide methotrexate, and etoposide (IMVP) as a salvage therapy for relapsed and refractory aggressive Non-Hodgkin lymphoma : retrospective study." 2002: 3.

MLA stil citiranja

Aurer, Igor, et al. "Combination of ifosfamide methotrexate, and etoposide (IMVP) as a salvage therapy for relapsed and refractory aggressive Non-Hodgkin lymphoma: Combination of ifosfamide methotrexate, and etoposide (IMVP) as a salvage therapy for relapsed and refractory aggressive Non-Hodgkin lymphoma : retrospective study." 2002: 3.